423 related articles for article (PubMed ID: 9727024)
1. p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway.
Patrick GN; Zhou P; Kwon YT; Howley PM; Tsai LH
J Biol Chem; 1998 Sep; 273(37):24057-64. PubMed ID: 9727024
[TBL] [Abstract][Full Text] [Related]
2. Influence of phosphorylation of p35, an activator of cyclin-dependent kinase 5 (cdk5), on the proteolysis of p35.
Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
Brain Res Mol Brain Res; 2002 Oct; 106(1-2):50-6. PubMed ID: 12393264
[TBL] [Abstract][Full Text] [Related]
3. Two Degradation Pathways of the p35 Cdk5 (Cyclin-dependent Kinase) Activation Subunit, Dependent and Independent of Ubiquitination.
Takasugi T; Minegishi S; Asada A; Saito T; Kawahara H; Hisanaga S
J Biol Chem; 2016 Feb; 291(9):4649-57. PubMed ID: 26631721
[TBL] [Abstract][Full Text] [Related]
4. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
Hisanaga S; Saito T
Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
[TBL] [Abstract][Full Text] [Related]
5. Okadaic acid-stimulated degradation of p35, an activator of CDK5, by proteasome in cultured neurons.
Saito T; Ishiguro K; Onuki R; Nagai Y; Kishimoto T; Hisanaga S
Biochem Biophys Res Commun; 1998 Nov; 252(3):775-8. PubMed ID: 9837783
[TBL] [Abstract][Full Text] [Related]
6. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5.
Tsai LH; Delalle I; Caviness VS; Chae T; Harlow E
Nature; 1994 Sep; 371(6496):419-23. PubMed ID: 8090221
[TBL] [Abstract][Full Text] [Related]
7. The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation.
Nikolic M; Dudek H; Kwon YT; Ramos YF; Tsai LH
Genes Dev; 1996 Apr; 10(7):816-25. PubMed ID: 8846918
[TBL] [Abstract][Full Text] [Related]
8. Cyclin-dependent kinase activity is required for apoptotic death but not inclusion formation in cortical neurons after proteasomal inhibition.
Rideout HJ; Wang Q; Park DS; Stefanis L
J Neurosci; 2003 Feb; 23(4):1237-45. PubMed ID: 12598612
[TBL] [Abstract][Full Text] [Related]
9. Developmental regulation of the proteolysis of the p35 cyclin-dependent kinase 5 activator by phosphorylation.
Saito T; Onuki R; Fujita Y; Kusakawa G; Ishiguro K; Bibb JA; Kishimoto T; Hisanaga S
J Neurosci; 2003 Feb; 23(4):1189-97. PubMed ID: 12598607
[TBL] [Abstract][Full Text] [Related]
10. Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity.
Tomizawa K; Ohta J; Matsushita M; Moriwaki A; Li ST; Takei K; Matsui H
J Neurosci; 2002 Apr; 22(7):2590-7. PubMed ID: 11923424
[TBL] [Abstract][Full Text] [Related]
11. Pctaire1 interacts with p35 and is a novel substrate for Cdk5/p35.
Cheng K; Li Z; Fu WY; Wang JH; Fu AK; Ip NY
J Biol Chem; 2002 Aug; 277(35):31988-93. PubMed ID: 12084709
[TBL] [Abstract][Full Text] [Related]
12. The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity.
Nikolic M; Chou MM; Lu W; Mayer BJ; Tsai LH
Nature; 1998 Sep; 395(6698):194-8. PubMed ID: 9744280
[TBL] [Abstract][Full Text] [Related]
13. Enhanced activation of Ca2+/calmodulin-dependent protein kinase II upon downregulation of cyclin-dependent kinase 5-p35.
Hosokawa T; Saito T; Asada A; Ohshima T; Itakura M; Takahashi M; Fukunaga K; Hisanaga S
J Neurosci Res; 2006 Sep; 84(4):747-54. PubMed ID: 16802322
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.
Meijer L; Borgne A; Mulner O; Chong JP; Blow JJ; Inagaki N; Inagaki M; Delcros JG; Moulinoux JP
Eur J Biochem; 1997 Jan; 243(1-2):527-36. PubMed ID: 9030781
[TBL] [Abstract][Full Text] [Related]
15. Cyclin-dependent kinase 5 (Cdk5) and neuron-specific Cdk5 activators.
Tang D; Wang JH
Prog Cell Cycle Res; 1996; 2():205-16. PubMed ID: 9552397
[TBL] [Abstract][Full Text] [Related]
16. The presence of active Cdk5 associated with p35 in astrocytes and its important role in process elongation of scratched astrocyte.
He Y; Li HL; Xie WY; Yang CZ; Yu AC; Wang Y
Glia; 2007 Apr; 55(6):573-83. PubMed ID: 17295212
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of cyclin-dependent kinase 5 (Cdk5) at Tyr-15 is inhibited by Cdk5 activators and does not contribute to the activation of Cdk5.
Kobayashi H; Saito T; Sato K; Furusawa K; Hosokawa T; Tsutsumi K; Asada A; Kamada S; Ohshima T; Hisanaga S
J Biol Chem; 2014 Jul; 289(28):19627-36. PubMed ID: 24872417
[TBL] [Abstract][Full Text] [Related]
18. Identification of functional domains in the neuronal Cdk5 activator protein.
Poon RY; Lew J; Hunter T
J Biol Chem; 1997 Feb; 272(9):5703-8. PubMed ID: 9038181
[TBL] [Abstract][Full Text] [Related]
19. Induction of cyclin-dependent kinase 5 and its activator p35 through the extracellular-signal-regulated kinase and protein kinase A pathways during retinoic-acid mediated neuronal differentiation in human neuroblastoma SK-N-BE(2)C cells.
Lee JH; Kim KT
J Neurochem; 2004 Nov; 91(3):634-47. PubMed ID: 15485494
[TBL] [Abstract][Full Text] [Related]
20. The protein SET binds the neuronal Cdk5 activator p35nck5a and modulates Cdk5/p35nck5a activity.
Qu D; Li Q; Lim HY; Cheung NS; Li R; Wang JH; Qi RZ
J Biol Chem; 2002 Mar; 277(9):7324-32. PubMed ID: 11741927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
